7Baggers
 vigil neuroscience inc (vigl) institutional confidence  TradingKey Thu, 18 Jun 2026 06:35:56 GMT
 vigil neuroscience, inc. - common stock (nq: vigl  FinancialContent Thu, 14 May 2026 12:43:02 GMT
 vigl sec filings - vigil neuroscience, inc. 10-k, 10-q, 8-k forms  Stock Titan Thu, 02 Apr 2026 07:47:08 GMT
 Triveni Bio Leases Top Floor at Watertown Life Sciences Building  Boston Real Estate Times Thu, 19 Mar 2026 07:00:00 GMT
 Changing Faces: Pharma and biotech hires, November and December 2025  pharmaphorum Wed, 14 Jan 2026 08:00:00 GMT
 ovid therapeutics appoints kaufmann as chief medical officer  TipRanks Tue, 02 Dec 2025 08:00:00 GMT
 Ivana Magovčević-Liebisch  PharmaTimes Mon, 01 Dec 2025 08:00:00 GMT
 using portfolio simulators with vigil neuroscience inc. included  newser.com Thu, 20 Nov 2025 05:42:47 GMT
 recursion refreshes leadership with ceo swap—chutes & ladders  Fierce Biotech Fri, 07 Nov 2025 08:00:00 GMT
 sanofi to buy vigil neuroscience for about $470 million  MSN Wed, 05 Nov 2025 16:46:27 GMT
 sanofi to acquire vigil neuroscience in $470-m deal  MSN Tue, 04 Nov 2025 01:24:23 GMT
 ivana magovčević-liebisch named president and ceo at draig  The Pharma Letter Mon, 03 Nov 2025 08:00:00 GMT

Vigil Neuroscience, Inc.
(NASDAQ:VIGL) 

VIGL stock logo

Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, t...

Founded: 2020
IPO Price: $14 (Jan 07, 2022)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends